Innovative Psychedelics, a clinic at the forefront of mental health treatments, has announced the availability of new patient appointments for IV ketamine therapy. This treatment is aimed at individuals battling severe depression, mood disorders, and chronic pain, offering hope to those who have found little relief from traditional therapies. The clinic's team of medical professionals utilizes the latest technology to deliver personalized care, ensuring each patient's treatment plan is tailored to their specific needs.
Among the conditions treated are cancer-related pain, CRPS, fibromyalgia, neuropathic pain, phantom pain, postherpetic neuralgia, sickle cell disease, and spinal injuries. The treatment involves a three-hour infusion, typically administered once a month. It's important for potential patients to understand that ketamine infusion for mood or pain disorders is considered off-label use and is not FDA-approved for these purposes. Possible side effects include high blood pressure, nausea, vomiting, and perceptual disturbances.
Innovative Psychedelics has also gained recognition for its successful introduction of Spravato treatments, further solidifying its position as a leader in innovative mental health solutions. With locations in both Chicago and Downers Grove, IL, the clinic is expanding access to these cutting-edge treatments. For more information on their services, including contact details and hours of operation, interested individuals are encouraged to visit the clinic's website.
